Stock Research: 10x Genomics

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

10x Genomics

NSQ:TXG US88025U1097
21
  • Value
    51
  • Growth
    57
  • Safety
    Safety
    27
  • Combined
    34
  • Sentiment
    23
  • 360° View
    360° View
    21
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

10x Genomics, Inc. is a life science technology company providing integrated solutions for single cell and spatial biology. Its main businesses include instruments, consumables, and software for Chromium and Visium platforms, supporting single cell gene expression, immune profiling, ATAC, and spatial gene expression. The company operates globally. In the last fiscal year, the company had a market cap of $1,533 million, profits of $415 million, revenue of $611 million, and 1,306 employees.

more
Index
NASDAQ
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 27-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
51 55 12 9
Growth
57 19 59 59
Safety
Safety
27 75 60 54
Sentiment
23 9 79 71
360° View
360° View
21 18 61 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
6 20 39 38
Opinions Change
50 6 50 50
Pro Holdings
n/a 8 65 69
Market Pulse
84 60 89 70
Sentiment
23 9 79 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
51 55 12 9
Growth
57 19 59 59
Safety Safety
27 75 60 54
Combined
34 44 40 28
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
45 61 11 9
Price vs. Earnings (P/E)
97 12 12 4
Price vs. Book (P/B)
39 53 12 6
Dividend Yield
1 1 1 1
Value
51 55 12 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
21 60 79 82
Profit Growth
4 36 21 91
Capital Growth
89 44 4 7
Stock Returns
87 7 91 33
Growth
57 19 59 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
76 100 100 100
Refinancing
43 63 33 31
Liquidity
12 1 12 7
Safety Safety
27 75 60 54

Similar Stocks

Discover high‑ranked alternatives to 10x Genomics and broaden your portfolio horizons.

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Omnicom

NYQ:OMC
Country: USA
Industry: Advertising
Size: X-Large
Full Stock Analysis

Mosaic

NYQ:MOS
Country: USA
Industry: Fertilizers & Agricultural Chemicals
Size: X-Large
Full Stock Analysis

Labcorp

NYQ:LH
Country: USA
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: